Paula Hutton
Impact in
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Epidemiology top 2%
- Sepsis Diagnosis and Treatment
- Pneumonia and Respiratory Infections
Papers in
-
- COVID-19 Clinical Research Studies 18
- SARS-CoV-2 and COVID-19 Research 2
- Epidemiology 15
- Sepsis Diagnosis and Treatment 15
- Co-authors
- Charles Hinds (11 shared papers)Anthony C. Gordon (10 shared papers)Christopher S. Garrard (8 shared papers)Julian Charles Knight (4 shared papers)Emma E. Davenport (4 shared papers)Katie L. Burnham (4 shared papers)Adrian V. S. Hill (3 shared papers)Peter Humburg (2 shared papers)
- Journals
- The Lancet (6 papers)JAMA (6 papers)Nature (4 papers)Critical Care (4 papers)The Lancet Respiratory Medicine (3 papers)
- Partner nations
- United KingdomSwitzerlandFrance
In The Last Decade
Paula Hutton
49 papers receiving 5k citations
Paula Hutton's Hit Papers
Peers
Comparison fields: 5 of 115
- Infectious Diseases 2.3k
- Epidemiology 1.2k
- Genetics 582
- Applied Microbiology and Biotechnology 40
- Internal Medicine 46
Countries citing papers authored by Paula Hutton
This map shows the geographic impact of Paula Hutton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula Hutton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula Hutton more than expected).
Fields of papers citing papers by Paula Hutton
This network shows the impact of papers produced by Paula Hutton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula Hutton. The network helps show where Paula Hutton may publish in the future.
Co-authors
The 25 scholars most cited alongside Paula Hutton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 2 | Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study Hit paper breakdown → | 2016 | 641 |
| 3 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 4 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 5 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 6 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 233 |
| 7 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 8 | A blood atlas of COVID-19 defines hallmarks of disease severity and specificity Hit paper breakdown → | 2022 | 225 |
| 9 | 2021 | 213 | |
| 10 | 2017 | 198 | |
| 11 | 2021 | 166 | |
| 12 | 2014 | 157 | |
| 13 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 125 |
| 14 | 2014 | 123 | |
| 15 | 2022 | 105 | |
| 16 | 2022 | 100 | |
| 17 | 2017 | 99 | |
| 18 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 19 | 2022 | 73 | |
| 20 | 2021 | 72 |
About Paula Hutton
Paula Hutton is a scholar working on Infectious Diseases, Epidemiology, Critical Care and Intensive Care Medicine, Genetics and Anesthesiology and Pain Medicine, having authored 49 papers that have together received 5.1k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (18 papers), Sepsis Diagnosis and Treatment (15 papers), Genetic Associations and Epidemiology (7 papers), Respiratory Support and Mechanisms (3 papers), Intensive Care Unit Cognitive Disorders (2 papers), Anesthesia and Sedative Agents (2 papers), Palliative Care and End-of-Life Issues (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Infectious Diseases (2.3k citations), Epidemiology (1.2k citations), Genetics (582 citations), Applied Microbiology and Biotechnology (40 citations) and Internal Medicine (46 citations). Paula Hutton has collaborated with scholars based in United Kingdom, Switzerland and France. Frequent co-authors include Charles Hinds, Anthony C. Gordon, Christopher S. Garrard, Julian Charles Knight, Emma E. Davenport, Katie L. Burnham, Adrian V. S. Hill, Peter Humburg, Jayachandran Radhakrishnan and Tara C. Mills. Their work appears in journals such as The Lancet, JAMA, Nature, Critical Care and The Lancet Respiratory Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.